Join us for the third session in Lumanity’s New Cancer Progress Webinar series, “On the Backside of the Hype Cycle: Cancer Cell Therapy Companies Grappling With Lofty Expectations and Challenging Market Conditions,” on April 26th at 1:00pm ET moderated by Joel Sandler, Ph.D..
Hear from Mike DeRidder, Ajla Hrle, Michael Kalos, and Paul Lammers as they discuss implications and strategic considerations for companies grappling with skepticism from partners, investors, clinical/regulatory, and commercial perspectives.
